drugset / Trial / NCT01205477

Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment

NCT01205477

Phase 2 Completed 58 enrolled Autonomous University of Nuevo León
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment

Timeline

Start
2009-09
Primary completion
2010-07
Completion
2010-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 40 mg Other
Background Diclofenac Other / unclassified 100 mg Oral
Background Lidocaine Other / unclassified 1 ml Other

Indications